Glen Rock, NJ, United States of America

Saul Liss

This inventor holds 16 USPTO granted patents, primarily in Neuroaugmentative Technology. Top assignees: Pain Suppression Labs, E.p. Limited, Medi Consultants, Inc.. Active years: 1985-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saul Liss. Retrieved from https://idiyas.com/inventor/saul-liss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 15

Forward Citations = 1,089(Granted Patents)


Location History:

  • Glen Rock, NJ (US) (1985 - 1995)
  • Hawthorne, NJ (US) (1996 - 1998)

Company Filing History:


Years Active: 1985-1998

Loading Chart...
Areas of Expertise:
Neuroaugmentative
Analgesic System
Dental Analgesia
Cerebral Palsy
Iontophoresis
Headache Treatment
Migraine Modulator
Glaucoma Treatment
Therapeutic Device
Pain Dysfunction
Multiple Sclerosis
Transcranial Stimulation
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Saul Liss

Introduction

Saul Liss is a notable inventor based in Glen Rock, NJ, with a remarkable portfolio of 16 patents. His work primarily focuses on advancements in medical technology and therapeutic methods. Liss's inventions aim to improve patient care and enhance the effectiveness of treatments for various health conditions.

Latest Patents

Among his latest patents is the "Combination Non-Intrusive Analgesic Neuroaugmentive System and Method." This invention provides a system and apparatus for treating neurally responsive conditions using a novel combined waveform, which is modulated onto a gigaTENS waveform administered to patients. This innovative approach can be applied synchronously or asynchronously with conventional waveforms, making it useful for TENS applications and stimulatory input. Another significant patent is the "Method for Enhancement of Dehydroepiandrosterone." This method enhances serum dehydroepiandrosterone (DHEA) levels in humans, improving their response to infections and resistance to pathogenic organisms. The serum concentration of DHEA is elevated through topically applied preparations containing progesterone, using electronic stimulators on specific acupuncture points, or a combination of both methods.

Career Highlights

Throughout his career, Saul Liss has made significant contributions to the field of medical technology. His innovative approaches have led to advancements that benefit patients and healthcare providers alike. Liss has worked with various companies, including Pain Suppression Labs and E.P. Limited, where he has applied his expertise to develop effective therapeutic solutions.

Collaborations

Saul Liss has collaborated with notable individuals in his field, including Bernard S. Liss and C. Norman Shealy. These collaborations have further enriched his work and contributed to the development of his innovative inventions.

Conclusion

Saul Liss's contributions to medical technology through his patents and collaborations highlight his commitment to improving patient care. His innovative inventions continue to pave the way for advancements in therapeutic methods and medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…